Elanco Animal Health Inc
F:5EA

Watchlist Manager
Elanco Animal Health Inc Logo
Elanco Animal Health Inc
F:5EA
Watchlist
Price: 18.658 EUR -1.02% Market Closed
Market Cap: 9.2B EUR

Net Margin
Elanco Animal Health Inc

0.8%
Current
-7%
Average
4.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0.8%
=
Net Income
36m
/
Revenue
4.6B

Net Margin Across Competitors

No Stocks Found

Elanco Animal Health Inc
Glance View

Elanco Animal Health Inc. emerged from the hallowed halls of Eli Lilly and Company, officially standing on its own in 2018, and immediately carving out its identity as a key player in animal health. The company, headquartered in Greenfield, Indiana, prides itself on working at the intersection of science and animal well-being, bringing innovative solutions to the market. Elanco's operations revolve around two primary business segments: Companion Animal and Farm Animal. In the Companion Animal segment, the focus is squarely on developing products that improve the health and extend the lives of pets, from flea and tick treatments to vaccines that safeguard them against disease. This segment taps into the growing humanization of pets, leveraging the emotional bond between owners and animals to drive demand for premium pet healthcare products. On the other hand, Elanco's Farm Animal segment is deeply woven into the fabric of the agricultural ecosystem, serving the needs of livestock operations around the globe. This division offers a suite of products that enhance the health and productivity of cattle, swine, poultry, and aqua species, addressing concerns from disease prevention to growth efficiency. By providing antibiotics, vaccines, and other nutritional health additives, Elanco helps farmers meet the world's growing demand for protein while complying with the ever-stringent regulations on animal product safety and efficacy. The company's diversified portfolio and its global reach allow it to monetize the vast and varied animal health landscape effectively, positioning itself as a stalwart in the sector dedicated not just to animal care but to elevating the industry standards through innovation and responsible growth.

5EA Intrinsic Value
17.504 EUR
Overvaluation 6%
Intrinsic Value
Price
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0.8%
=
Net Income
36m
/
Revenue
4.6B
What is the Net Margin of Elanco Animal Health Inc?

Based on Elanco Animal Health Inc's most recent financial statements, the company has Net Margin of 0.8%.

Back to Top